Targeting of CD44 by miRNA-34a suppresses regeneration and metastatic potential of prostate CSCs Feb. 2, 2011
Updated data disclosed from RADIANT-2 and -3 trials of everolimus in neuroendocrine tumors Feb. 2, 2011
First-line TH-302 plus gemcitabine shows promise in advanced/metastatic pancreatic cancer Feb. 1, 2011
RSS